MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02422381 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 21, 2015
Last Update Posted : September 10, 2022
|
Sponsor:
Providence Health & Services
Collaborators:
Merck Sharp & Dohme LLC
Providence Cancer Center, Earle A. Chiles Research Institute
Information provided by (Responsible Party):
Providence Health & Services
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2023 |
| Estimated Study Completion Date : | August 2024 |